NextPlat (NXPL) Amortizatization of Intangibles (2010 - 2026)
NextPlat's (NXPL) quarterly Amortizatization of Intangibles came in at $63000.0 in Q2 2026, down 29.21% year-over-year from $89000.0 in Q2 2025, and up 6.78% quarter-over-quarter from $59000.0 in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Amortizatization of Intangibles for 12 consecutive years, with $63000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 29.21% year-over-year to $63000.0 in Q2 2026; TTM through Jun 2026 was $331000.0, a 23.51% increase from a year earlier, with the FY2025 full-year figure at $396000.0, up 21.85% from the prior year.
- Amortizatization of Intangibles was $63000.0 for Q2 2026 at NextPlat, up from $59000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $229000.0 in Q4 2023 and troughed at -$8803.0 in Q2 2022.
- A 5-year average of $75888.9 and a median of $73500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 211.25% in 2022 and jumped 3300.0% in 2025, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $47716.0 in 2022, then soared by 379.92% to $229000.0 in 2023, then sank by 63.32% to $84000.0 in 2024, then jumped by 34.52% to $113000.0 in 2025, then sank by 44.25% to $63000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $63000.0 (Q2 2026), $59000.0 (Q1 2026), and $113000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 456,000.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 2.15 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 63,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,000.00 |
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | 113,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | 115,000.00 |
| Mar 31, 2024 | 129,000.00 |
| Dec 31, 2023 | 229,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 47,716.00 |
| Sep 30, 2022 | 58,284.00 |
| Jun 30, 2022 | -8,803.00 |
| Mar 31, 2022 | 8,803.00 |
| Dec 31, 2021 | 8,015.00 |
| Sep 30, 2021 | 9,472.00 |